COX6CP5

Across TCGA pan-cancer cohorts, COX6CP5 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated COX6CP5 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher COX6CP5 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated COX6CP5 expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

READ, UVM, and KICH are the cancer types where COX6CP5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Tertile	II,III,IV	0.555	0.919	<.001	126	view →
UVM	OS	Tertile	All	0.037	0.858	<.001	108	view →
KICH	DFS	Tertile	All	0.081	0.904	<.001	90	view →
LIHC	DFS	Tertile	All	0.116	0.545	.001	63	view →
BRCA	OS	Tertile	IV	0.233	0.755	.038	36	view →
HNSC	OS	Tertile	III,IV	0.001	0.675	<.001	36	view →
UCEC	OS	Tertile	All	0.746	0.878	.015	30	view →
TGCT	DFS	Tertile	II,III,IV	0.088	0.917	.010	18	view →
STAD	OS	Tertile	IV	0.630	0.256	.048	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

COX6CP5–READ (OS)

Open the READ breakdown →